Related Experiment Videos
Penicillamine-induced pemphigus foliaceus. A fatal outcome
Archives of Dermatology
|March 1, 1981
Abstract:
Penicillamine-induced pemphigus is an uncommon but well-recognized phenomenon. It has been generally believed to be a benign disease responding to withdrawal of the drug or to treatment with a short course of oral steroids. In the hope that it will increase awareness of the potential severity of this disease, we report herein a case of penicillamine-induced pemphigus foliaceus with fatal termination.
Insights
Penicillamine-induced pemphigus, though usually benign, can be severe. This case highlights a fatal outcome of penicillamine-induced pemphigus foliaceus, emphasizing the need for increased awareness of its potential severity.
Area of Science:
- Dermatology
- Autoimmune blistering diseases
Background:
- Penicillamine-induced pemphigus is an uncommon autoimmune condition.
- It is typically considered benign and responsive to drug withdrawal or short-term steroid treatment.
Observation:
- This report details a rare case of penicillamine-induced pemphigus foliaceus.
- The patient experienced a fatal termination from the condition.
Findings:
- Penicillamine-induced pemphigus foliaceus can present with severe morbidity and mortality.
- The presumed benign nature of this drug-induced pemphigus may not always hold true.
Implications:
- Clinicians should be aware of the potential for severe outcomes in penicillamine-induced pemphigus.
- This case underscores the importance of vigilant monitoring and prompt management of drug-induced dermatoses.